F21 - Navigating Menopausal Symptoms: Treatment Considerations for Individuals with Diabetes

Friday, August 8, 2025

3:30 PM - 4:15 PM MST

CE/CME Hours: .75 CE

Pharmacology Hours: .50 CE

The menopausal transition is accompanied by cardiometabolic changes that impact the risk for and management of diabetes. This presentation will explore benefits and concerns associated with hormonal and non-hormonal drug therapies commonly used for the treatment of menopausal symptoms in those with diabetes. Case scenarios will focus on individualized decision making to balance menopausal symptom management, optimal glucose management, and cardiovascular safety. Considerations for supporting communication of menopause and diabetes goals across the care team will be emphasized.

Disclosure(s):

Erin Raney, PharmD, RPh, BC-ADM, BCPS: No financial relationships to disclose

Primary Presenter(s)

Erin Raney, PharmD, BC-ADM, BCPS (she/her/hers)

Professor of Pharmacy Practice
Midwestern University College of Pharmacy
GLENDALE, Arizona

Disclosure(s): No financial relationships to disclose

Session Host(s)

Kristine Batty, Ph.D, APRN, BC-ADM, CDCES, FADCES

Nurse Practitioner
University of Maryland BAltimore Washington Medical Center
Columbia, Maryland

Disclosure information not submitted.